Scholarly publishing renders a great service
to science, research and academic literature. The industry is largely dominated
by subscription-based publishing which has existed for as long as the scholarly
journals publishing itself (Paul Peters, 2007). Academic journals and the
quality of the research published in them are judged by their impact factor, a
measure of the number of citations to articles published in the journals.
Bentham Science is a rapidly growing
scholarly journal publisher and has been serving the academia and libraries for
the last 25 years. They publish 122 subscription based journals, while their
flagship products include 32 journals with impact factors. Current Gene Therapy
has an impact factor of 5.318 and is considered to be one of the most popular
peer-reviewed journals in the field of gene and cell therapy. It publishes the
latest research and review articles on the academic and clinical applications
and experimental data on gene therapy.
Bentham Science Publishers’ Current Drug Metabolism
also enjoys a high impact factor of 4.405. Current Drug Metabolism is indexed
in major abstracting agencies like Scopus, MEDLINE, Journal Citation Reports, Biochemistry & Biophysics Citation
Index, etc. It publishes review articles and thematic guest edited
issues on the latest developments in the area of drug metabolism.
Current Molecular Medicine (Impact Factor: 4.197) covers the recent
developments in the fundamental molecular mechanisms of disease pathogenesis,
and the development of molecular-diagnosis and/or novel approaches to rational
treatment. For a complete list of Bentham Science Publishers’ High Impact
Factor Journals, kindly log on to http://benthamscience.com/IFTitles.htm and
No comments:
Post a Comment